FNY Investment Advisers LLC Purchases 28,613 Shares of Core Scientific, Inc. (NASDAQ:CORZ)

FNY Investment Advisers LLC boosted its stake in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 15.0% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 219,360 shares of the company's stock after acquiring an additional 28,613 shares during the quarter. Core Scientific accounts for about 1.0% of FNY Investment Advisers LLC's portfolio, making the stock its 22nd biggest holding. FNY Investment Advisers LLC owned 0.07% of Core Scientific worth $1,588,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Xponance Inc. lifted its holdings in Core Scientific by 7.9% during the 4th quarter. Xponance Inc. now owns 12,800 shares of the company's stock worth $180,000 after buying an additional 937 shares in the last quarter. Summit Investment Advisors Inc. increased its holdings in shares of Core Scientific by 6.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 18,658 shares of the company's stock valued at $262,000 after purchasing an additional 1,185 shares during the period. Wellington Shields & Co. LLC acquired a new stake in Core Scientific in the fourth quarter valued at $26,000. First Horizon Advisors Inc. purchased a new stake in shares of Core Scientific in the fourth quarter valued at $34,000. Finally, Victory Capital Management Inc. lifted its position in Core Scientific by 12.2% during the fourth quarter. Victory Capital Management Inc. now owns 29,890 shares of the company's stock worth $420,000 after buying an additional 3,257 shares during the period.

Analyst Ratings Changes

A number of equities analysts have issued reports on CORZ shares. JMP Securities began coverage on Core Scientific in a research report on Thursday, May 22nd. They issued a "market outperform" rating and a $15.00 target price on the stock. Cantor Fitzgerald dropped their target price on Core Scientific from $24.00 to $21.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Citizens Jmp raised Core Scientific to a "strong-buy" rating and set a $15.00 price objective on the stock in a report on Thursday, May 22nd. Canaccord Genuity Group reiterated a "buy" rating and issued a $17.00 price objective on shares of Core Scientific in a research report on Friday, May 9th. Finally, Citigroup began coverage on Core Scientific in a research report on Thursday, May 22nd. They issued an "outperform" rating for the company. Eighteen investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Core Scientific currently has an average rating of "Buy" and a consensus price target of $18.44.

Insider Transactions at Core Scientific

In related news, Director Yadin Rozov purchased 110,000 shares of the stock in a transaction that occurred on Wednesday, May 28th. The stock was acquired at an average cost of $10.87 per share, with a total value of $1,195,700.00. Following the transaction, the director now owns 475,687 shares of the company's stock, valued at $5,170,717.69. This represents a 30.08% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Todd M. Duchene sold 50,000 shares of the stock in a transaction on Wednesday, June 4th. The stock was sold at an average price of $12.31, for a total value of $615,500.00. Following the transaction, the insider now owns 2,050,102 shares of the company's stock, valued at $25,236,755.62. The trade was a 2.38% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.40% of the company's stock.

Core Scientific Price Performance

NASDAQ CORZ traded down $0.19 during trading on Tuesday, reaching $11.89. 7,055,008 shares of the company's stock were exchanged, compared to its average volume of 12,851,938. Core Scientific, Inc. has a fifty-two week low of $6.20 and a fifty-two week high of $18.63. The business has a 50 day moving average price of $9.68 and a 200-day moving average price of $11.25.

Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.02. The company had revenue of $79.53 million during the quarter, compared to the consensus estimate of $92.04 million. During the same quarter last year, the firm posted $0.78 earnings per share. The company's quarterly revenue was down 55.6% on a year-over-year basis. On average, analysts predict that Core Scientific, Inc. will post 0.52 EPS for the current year.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.